JP2023536086A5 - - Google Patents
Info
- Publication number
- JP2023536086A5 JP2023536086A5 JP2023505707A JP2023505707A JP2023536086A5 JP 2023536086 A5 JP2023536086 A5 JP 2023536086A5 JP 2023505707 A JP2023505707 A JP 2023505707A JP 2023505707 A JP2023505707 A JP 2023505707A JP 2023536086 A5 JP2023536086 A5 JP 2023536086A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- bispecific molecule
- ctla
- use according
- cdr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063057054P | 2020-07-27 | 2020-07-27 | |
| US63/057,054 | 2020-07-27 | ||
| US202163177036P | 2021-04-20 | 2021-04-20 | |
| US63/177,036 | 2021-04-20 | ||
| US202163219066P | 2021-07-07 | 2021-07-07 | |
| US63/219,066 | 2021-07-07 | ||
| PCT/US2021/042901 WO2022026306A1 (en) | 2020-07-27 | 2021-07-23 | Methods for the use of a pd-1 x ctla-4 bispecific molecule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536086A JP2023536086A (ja) | 2023-08-23 |
| JP2023536086A5 true JP2023536086A5 (https=) | 2024-07-29 |
Family
ID=80036053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505707A Pending JP2023536086A (ja) | 2020-07-27 | 2021-07-23 | Ｐｄ‐１×ｃｔｌａ‐４二重特異性分子の使用のための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230312756A1 (https=) |
| EP (1) | EP4188961A4 (https=) |
| JP (1) | JP2023536086A (https=) |
| KR (1) | KR20230042038A (https=) |
| CN (1) | CN116134053A (https=) |
| AU (1) | AU2021316192A1 (https=) |
| BR (1) | BR112023001487A2 (https=) |
| CA (1) | CA3189926A1 (https=) |
| IL (1) | IL300166A (https=) |
| MX (1) | MX2023001111A (https=) |
| TW (1) | TW202220691A (https=) |
| WO (1) | WO2022026306A1 (https=) |
| ZA (1) | ZA202300822B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120648657A (zh) * | 2024-03-08 | 2025-09-16 | 上海锦斯生物技术有限公司 | 一种修饰的溶瘤病毒及其组合物 |
| WO2026021409A1 (zh) * | 2024-07-22 | 2026-01-29 | 宜明昂科生物医药技术（上海）股份有限公司 | 靶向ctla-4、pd-l1和vegf的肿瘤联合疗法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2439273T3 (da) * | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| IL260021B (en) * | 2015-12-14 | 2022-09-01 | Macrogenics Inc | Bispecific molecules that are immunoreactive for pd1 and ctla4 and methods for using them |
| AR108377A1 (es) * | 2016-05-06 | 2018-08-15 | Medimmune Llc | Proteínas de unión biespecíficas y sus usos |
| JP7010854B2 (ja) * | 2016-06-14 | 2022-01-26 | ゼンコア インコーポレイテッド | 二重特異性チェックポイント阻害剤抗体 |
| WO2018014260A1 (en) * | 2016-07-20 | 2018-01-25 | Nanjing Legend Biotech Co., Ltd. | Multispecific antigen binding proteins and methods of use thereof |
| CN106967172B (zh) * | 2016-08-23 | 2019-01-08 | 康方药业有限公司 | 抗ctla4-抗pd-1 双功能抗体、其药物组合物及其用途 |
| WO2019179421A1 (en) * | 2018-03-19 | 2019-09-26 | Wuxi Biologics (Shanghai) Co., Ltd. | Novel bispecific pd-1/ctla-4 antibody molecules |
-
2021
- 2021-07-23 TW TW110127252A patent/TW202220691A/zh unknown
- 2021-07-23 IL IL300166A patent/IL300166A/en unknown
- 2021-07-23 CN CN202180059321.7A patent/CN116134053A/zh active Pending
- 2021-07-23 BR BR112023001487A patent/BR112023001487A2/pt unknown
- 2021-07-23 JP JP2023505707A patent/JP2023536086A/ja active Pending
- 2021-07-23 WO PCT/US2021/042901 patent/WO2022026306A1/en not_active Ceased
- 2021-07-23 US US18/006,294 patent/US20230312756A1/en active Pending
- 2021-07-23 EP EP21849290.8A patent/EP4188961A4/en active Pending
- 2021-07-23 CA CA3189926A patent/CA3189926A1/en active Pending
- 2021-07-23 KR KR1020237004873A patent/KR20230042038A/ko active Pending
- 2021-07-23 AU AU2021316192A patent/AU2021316192A1/en active Pending
- 2021-07-23 MX MX2023001111A patent/MX2023001111A/es unknown
-
2023
- 2023-01-18 ZA ZA2023/00822A patent/ZA202300822B/en unknown